The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care

Kidney International

Volumn 82, Issue 4, 2012, Pages 482-488

  De Nicola, Luca ^a   Minutolo, R ^a   Chiodini, Paolo ^a   Borrelli, Silvio ^a   Zoccali, Carmine ^b   Postorino, Maurizio ^b   Iodice, Carmela ^a   Nappi, Felice ^c   Fuiano, Giorgio ^d   Dal Canton, A ^e   Conte, Giuseppe ^a   Formica, M ^f   Segoloni, G ^g   Gallieni, M ^h   Locatelli, F ⁱ   Tarchini, R ^j   Oldrizzi, L ^l   Cossu, M ^m   Di Giulio, S ⁿ   Malaguti, M ^o   Pizzarelli, F ^p   Quintaliani, G ^q   Cianciaruso, B ^r   Pisani, A ^r   De Nicola, L ^a   Bonofiglio, R ^s   Fuiano, G ^d   Grandaliano, G ^t   Bellinghieri, G ^u   Santoro, D ^u   more..

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CNR   (Italy)

^c Nephrology Division   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

^f S Croce e Carle Hospital   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h SAN CARLO BORROMEO HOSPITAL   (Italy)

ⁱ A MANZONI HOSPITAL   (Italy)

^j C Poma Hospital   (Italy)

^k Dolo General Hospital   (Italy)

^l Section of Vascular Surgery   (Italy)

^m SS Annunziata Hospital   (Italy)

ⁿ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^o S Paolo Hospital ASL RMF   (Italy)

^p SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^q SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^r UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^s Ospedale dell'Annunziata   (Italy)

^t UNIVERSITY OF FOGGIA   (Italy)

^u UNIVERSITY OF MESSINA   (Italy)

more..

Author keywords

age; chronic kidney disease; elderly; ESRD; nephrology care; survival

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHATE; PROTEIN; SODIUM CHLORIDE; URIC ACID;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN INTAKE; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SURVIVAL FACTOR; SURVIVAL TIME; TREATMENT DURATION;

EID: 84864568733     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.174     Document Type: Article

References (33)

1. Prakash S, O'Hare AM. Interaction of aging and chronic kidney disease. Semin Nephrol 2009; 29: 497-503.
2. Anderson S, Halter JB, Hazzard WR et al. Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 2009; 20: 1199-1209.
3. Rosner M, Abdel-Rahman E, Williams ME. Geriatric nephrology: responding to a growing challenge. Clin J Am Soc Nephrol 2010; 5: 936-942.
4. Gambaro G, Yabarek T, Graziani MS et al. Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. Clin J Am Soc Nephrol 2010; 5: 1946-1953.
5. De Nicola L, Minutolo R, Chiodini P. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 2006; 69: 538-545.
6. Hoefield RA, Kalra PA, Baker P et al. Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis 2010; 56: 1072-1081.
7. Obi Y, Kimura T, Nagasawa Y et al. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol 2010; 5: 1558-1565.
8. Conway B, Webster A, Ramsay G et al. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant 2009; 24: 1930-1937.
9. Winkelmayer WC, Liu J, Chertow GM et al. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med 2011; 171: 1371-1378.
10. John R, Webb M, Young A et al. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004; 43: 825-835.
11. Patel UD, Young EW, Ojo AO et al. CKD progression and mortality among older patients with diabetes. Am J Kidney Dis 2005; 46: 406-414.
12. Minutolo R, De Nicola L, Zamboli P et al. Management of hypertension in patients with CKD: differences between primary and tertiary care settings. Am J Kidney Dis 2005; 46: 18-25.
13. Peralta CA, Shlipak MG, Fan D et al. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic vs. non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2892-2899.
14. Muntner P, Bowling CB, Gao L et al. Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality. Clin J Am Soc Nephrol 2011; 6: 2200-2207.
15. Hemmelgarn BR, Zhang J, Manns BJ et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 2006; 69: 2155-2161.
16. O'Hare AM, Choi AI, Bertenthal D et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007; 18: 2758-2765.
17. Hsu CY, Iribarren C, McCulloch CE et al. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009; 169: 342-350.
18. De Nicola L, Chiodini P, Zoccali C et al. Prognosis of CKD patients receiving outpatient nephrology care in Italy. Clin J Am Soc Nephrol 2011; 6: 2421-2428.
19. Fischer MJ, Stroupe KT, Kaufman JS et al. Predialysis nephrology care among older veterans using department of veterans affairs or medicarecovered services. Am J Manage Care 2010; 16: 57-66.
20. Eriksen BO, Ingebretsen OC. In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Kidney Int 2007; 72: 1242-1248.
21. Tseng CL, Kern EF, Miller DR et al. Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med 2008; 168: 55-62.
22. O'Hare AM. The management of older adults with a low eGFR: moving toward an individualized approach. Am J Kidney Dis 2009; 53: 925-927.
23. Fliser D, Zeier M, Nowack R et al. Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol 1993; 3: 1371-1377.
24. Fuiano G, Sund S, Mazza G et al. Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int 2001; 59: 1052-1058.
25. Rule AD, Amer H, Cornell LD et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 2010; 152: 561-567.
26. O'Hare AM, Hailpern SM, Pavkov ME et al. Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes. Arch Intern Med 2010; 170: 930-936.
27. O'Hare AM, Kaufman JS, Covinsky KE et al. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? Ann Intern Med 2009; 150: 717-724.
28. Dwyer J, Kenler SR. Assessment of nutritional status in renal disease. In: Mitch WE, Klahr S (eds). Nutrition and the Kidney, 2nd edn Little, Brown and Company: Boston, MA, 1993, pp 61-95.
29. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996; 17: 343-346.
30. Kochar SC, Lam KF, Yip PSF. Generalized supremum tests for the equality of cause specific hazard rates. Lifetime Data Anal 2002; 8: 277-288.
31. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. John Wiley: New York, NY, 1980.
32. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Statist Assoc 1999; 94: 496-509.
33. Harrell Jr FE, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 1988; 80: 1198-1202.